Cancer antigen 15-3 (CA15-3) antibody and antigen (Recombinant protein)

 Download 

Diagnostic Cancer antigen 15-3 (CA15-3) antibodies (anti-Cancer antigen 15-3, anti-CA15-3) and antigens (recombinant Cancer antigen 15-3 (CA15-3) protein) for Cancer CA15-3 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Cancer diagnostics products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-h-CA15-3-Ag01	Recombinant human CA15-3 Protein	$3090.00
GMP-h-CA15-3-Ab01	Anti-human CA15-3 mouse monoclonal antibody (mAb)	$1953.00
GMP-h-CA15-3-Ab02	Anti-human CA15-3 mouse monoclonal antibody (mAb)	$1953.00
GMP-h-CA15-3-Ab03	Anti-human CA15-3 human monoclonal antibody (mAb)	$1953.00
GMP-h-CA15-3-Ab04	Anti-human CA15-3 human monoclonal antibody (mAb)	$1953.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Pruducts	GMP-h-CA15-3-Ag01
Product Name	Recombinant human CA15-3 Protein
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	#N/A
Expression platform	mammalian
Isotypes	Recombinant Antigen
Bioactivity validation	Cancer antigen 15-3 (CA15-3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation
Products description	Recombinant Human Cancer antigen 15-3 (CA15-3) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts	GMP-h-CA15-3-Ab01,GMP-h-CA15-3-Ab02
Product Name	Anti-human CA15-3 mouse monoclonal antibody (mAb)
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	#N/A
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Human Cancer antigen 15-3 (CA15-3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human CA15-3 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies.
Reconized/Reactive Species	Human
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts	GMP-h-CA15-3-Ab03,GMP-h-CA15-3-Ab04
Product Name	Anti-human CA15-3 human monoclonal antibody (mAb)
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	#N/A
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Human Cancer antigen 15-3 (CA15-3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human CA15-3 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species	Human
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Cancer antigen 15-3 (CA15-3) test Cancer antigen 15-3 (CA15-3) is a protein made by a variety of cells, particularly breast cancer cells. The protein moves into the blood, where it can be measured. CA15-3 levels are higher than normal in most women with breast cancer that has spread to other parts of the body (called metastatic breast cancer). Not all types of breast cancer will cause CA 15-3 levels to rise, as some types of cancer cells don’t over-produce the antigen. Why a CA15-3 test is done CA15-3 is a tumour marker. It is used to check how breast cancer treatment is working and look for cancer that has come back, or recurred, after treatment. If you are diagnosed with breast cancer that has spread to other parts of the body, or metastasized, you may have this test, along with other tests such as hormone receptor testing and HER2 status testing. CA15-3 is not measured for early stage breast cancer because the levels of this protein are rarely higher than normal at this stage.

About GDU